<DOC>
	<DOCNO>NCT02512796</DOCNO>
	<brief_summary>Gadolinium contrast agent frequently administer MRI image . Very little known toxicity outside patient reduced renal function .</brief_summary>
	<brief_title>In Vitro Study Effect Gadolinium Contrast Fibrocytes</brief_title>
	<detailed_description>Gadolinium contrast administer patient MRI image . Recently , investigator observe potential gadolinium toxicity patient . To investigate , investigator propose collect clinical data lab data obtain part clinical care . The investigator also plan obtain 25 cc peripheral blood 2-4 week , 4-6 week 3 month identify unique monocyte signature , gene polymorphism , quantitate circulating fibrocytes ( fresh blood culture ) . Plan enroll 15 patient kidney , pancreas liver transplant expose gadolinium contrast agent , 15 non-transplant patient expose gadolinium contrast 30 age- sex-matched healthy control expose gadolinium contrast .</detailed_description>
	<criteria>Renal , pancreas liver transplant OR without organ transplant OR control Age 1870 Both gender Exposure gadolinium contrast agent ( exposure control ) Have transplant , contrast dye MRI Have transplant contrast dye MRI Healthy person MRI gadolinium reason . End stage kidney disease Stage 5 Previous diagnosis Nephrogenic Systemic Fibrosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Liver transplantation</keyword>
	<keyword>Renal transplantation</keyword>
	<keyword>Pancreas transplantation</keyword>
</DOC>